2017
DOI: 10.2174/1570180814666170602083756
|View full text |Cite
|
Sign up to set email alerts
|

An Improved Preparation of (R)-3-Aminobutanol, a Key Intermediate for the Synthesis of Dolutegravir Sodium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Integrase medicines can keep HIV from entering into DNA, 1 and thus they enable to avoid the replication of the DNA infected by HIV 2 . Dolutegravir (DTG, I in Scheme 1), that is, the second generation of integrase inhibitor, has the advantages of lower doses, 3 stronger resistance, 4 and fewer side effects 5 than the first generation. GlaxoSmithKline published the preparation method of DTG (Scheme 1) starting from methyl 4‐(methoxy)‐3‐carbonylbutyrate 6 .…”
Section: Introductionmentioning
confidence: 99%
“…Integrase medicines can keep HIV from entering into DNA, 1 and thus they enable to avoid the replication of the DNA infected by HIV 2 . Dolutegravir (DTG, I in Scheme 1), that is, the second generation of integrase inhibitor, has the advantages of lower doses, 3 stronger resistance, 4 and fewer side effects 5 than the first generation. GlaxoSmithKline published the preparation method of DTG (Scheme 1) starting from methyl 4‐(methoxy)‐3‐carbonylbutyrate 6 .…”
Section: Introductionmentioning
confidence: 99%